Position in HLN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,652
-$405 QoQ
Shares Held
713
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#513
of 639 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $7,070,693 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
207,575 | $5,108,420 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
31,507 | $1,067,457 | |
| 3 | DERM |
Journey Medical Corp
|
63,280 | $448,022 | |
| 4 | ZTS |
Zoetis Inc.
|
3,895 | $279,894 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
2,796 | $96,937 | |
| 6 | VTRS |
Viatris Inc
|
3,677 | $58,390 | |
| 7 | HLN |
Haleon plc
This page
|
713 | $6,652 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
307 | $4,921 |
All Filings in HLN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,652 | 713 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,057 | 705 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $10,504 | 1,039 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $9,319 | 1,039 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $48,127 | 4,641 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $89,821 | 8,729 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $34,754 | 3,643 | Shares | Sole | 2025-01-21 | |
| No filing history on record for this holder in this stock. | ||||||